Journal Article

Elucidating novel disease mechanisms in severe asthma

Balachandran, Lohis, Kim, Richard Y, Donovan, Chantal, Hansbro, Philip M, Knight, Darryl A, Rae, Brittany, Pinkerton, James, Horvat, Jay C, Starkey, Malcolm R, Neal, Rachel

2016

Overview

Corticosteroids are broadly active and potent anti‐inflammatory agents that, despite the introduction of biologics, remain as the mainstay therapy for many chronic inflammatory diseases, including inflammatory bowel diseases, nephrotic syndrome, rheumatoid arthritis, chronic obstructive pulmonary disease and asthma. Significantly, there are cohorts of these patients with poor sensitivity to steroid treatment even with high doses, which can lead to many iatrogenic side effects. The dose‐limiting toxicity of corticosteroids, and the lack of effective therapeutic alternatives, leads to substantial excess morbidity and healthcare expenditure. We have developed novel murine models of respiratory infection‐induced, severe, steroid‐resistant asthma that recapitulate the hallmark features of the human disease. These models can be used to elucidate novel disease mechanisms and identify new therapeutic targets in severe asthma. Hypothesis‐driven studies can elucidate the roles of specific factors and pathways. Alternatively, 'Omics approaches can be used to rapidly generate new targets. Similar approaches can be used in other diseases.

• Publisher: Nature Publishing Group,John Wiley & Sons, Inc
• Subject: Airway management / Animal models / Antigens / Asthma / Chlamydia / Chronic obstructive pulmonary disease / Corticosteroids / Cytokines / Edema / Inflammation / Inflammatory bowel diseases / Inflammatory diseases / Intestine / Lung diseases / Morbidity / Nephrotic syndrome / Neutrophils / Obstructive lung disease / Pathology / Population / Review / Rheumatoid arthritis / Smooth muscle / Therapeutic applications / Toxicity